Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Single-arm, Open-label Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations and Progressed On or After Applicable Targeted Therapy and Platinum Based Chemotherapy (TROPION-Lung05)

NCT04484142 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT04484142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04484142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Single-arm, Open-label Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations and Progressed On or After Applicable Targeted Therapy and Platinum Based Chemotherapy (TROPION-Lung05)
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Completed
Start date
March 30, 2021
Completion date
February 4, 2026
Enrollment
137 (actual)
Sites
84

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer